Glenmark starts Phase-3 clinical trials in india on antiviral drug Favipiravir
Glenmark starts Phase-3 clinical trials in India on antiviral drug Favipiravir Headline Second
Glenmark Pharmaceuticals has said in a statement that they have started Phase-3 clinical trials in India on antiviral tablet Favipiravir,....
Glenmark starts Phase-3 clinical trials in India on antiviral drug Favipiravir Headline Second
Glenmark Pharmaceuticals has said in a statement that they have started Phase-3 clinical trials in India on antiviral tablet Favipiravir,....